论文部分内容阅读
目的探讨由益生菌口服、溃结灌肠液气药灌肠及5-ASA制剂与结肠炎丸口服组合成的3种阶梯式递减治疗方案对活动期溃疡性结肠炎患者生存质量的影响。方法将72例活动期溃疡性结肠炎患者随机等分为3组。试验组采用3种阶梯递减治疗方案,对照Ⅰ组较试验组减少益生菌口服,对照Ⅱ组再减少溃结灌肠液气药灌肠。每例患者治疗前后分别填写《炎症性肠病生存质量问卷》,并对结果进行统计学分析。结果试验组有效观察16例,对照Ⅰ组15例,对照Ⅱ组21例。与治疗前相比,各组生存质量均有提高(P均<0.05),且试验组优于对照组。结论 3种治疗方案均可改善患者生存质量,试验组最优;但对照组病例脱落少,依从性较好;尤以对照Ⅱ组最为显著。试验组治疗获取不易及气液灌肠时的不适可能是患者依从性差的原因。
Objective To investigate the effects of three step-down regimens of probiotics oral administration, enema enema of ulcerative colitis enema and oral administration of 5-ASA and colitis pills on the quality of life of patients with active ulcerative colitis. Methods 72 patients with active ulcerative colitis were randomly divided into three groups. The experimental group used three kinds of step-down treatment regimens, control group Ⅰ compared with the test group to reduce the oral administration of probiotics, control group Ⅱ and then reduce ulceration enema intestinal enema. Each patient before and after treatment were filled in “inflammatory bowel disease quality of life questionnaire”, and the results were statistically analyzed. Results The experimental group effectively observed in 16 cases, control group Ⅰ 15 cases, control group Ⅱ 21 cases. Compared with before treatment, the quality of life in all groups increased (P <0.05), and the experimental group was better than the control group. Conclusion All the three treatments can improve the quality of life of patients, and the experimental group is the best. However, the patients in the control group shed less and the compliance is better, especially in the control group Ⅱ. Poor access to the experimental group and unpleasant gas-liquid enemas may account for poor patient compliance.